Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients

By                

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1882-1888

Spandidos Publications

Access to resources Recommend Favorite

Intratumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas

By                  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1719-1722

Spandidos Publications

Access to resources Recommend Favorite

Diagnostic Value of BRAF^V600E Mutation Analysis of Thyroid Nodules According to Ultrasonographic Features and the Time of Aspiration

By Moon Hee   Kim Eun-Kyung   Chung Woong   Choi Jong   Yoon Jung   Kwak Jin  

Annals of Surgical Oncology, Vol. 18, Iss. 3, 2011-03 ,pp. : 792-799

Springer Publishing Company

Access to resources Recommend Favorite

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms

By                        

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 548-556

Spandidos Publications

Access to resources Recommend Favorite